|
|
||||||||
1 Department of Pharmacology and Toxicology, Rutgers University and 2 Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854
The 60-kDa heat shock protein (HSP60), an
endogenous ligand for the toll-like 4 receptor, is generated in
response to inflammation, tissue injury, and/or stress and stimulates
macrophages to produce cytotoxic and proinflammatory mediators
including nitric oxide, tumor necrosis factor (TNF)-
, interleukin
(IL)-6, and IL-12. In the present studies we report that HSP60 is an
effective inducer of cyclooxygenase-2 (COX-2) in macrophages, as well
as endothelial cells. In both cell types, the synthesis of COX-2 was
coordinate with induction of nitric oxide synthase (NOS)-2 and
with nitric oxide production. With the use of promoter constructs in
transient transfection assays, optimal expression of COX-2 in
macrophages was found to require nuclear factor (NF)-
B, the
cAMP-response element (CRE), and NF-IL-6, but not the E-box. Mobility
shift assays revealed that HSP60 induced NF-
B and CRE binding
activity, while CCAAT/enhancer binding protein (C/EBP), which
binds to NF-IL-6, was constitutively active in the cells. Both c-Jun
and CRE binding protein (CREB) bound to the CRE, while
C/EBP-
bound to NF-IL-6. These data indicate that NF-
B,
C/EBP-
, c-Jun, and CREB are important in HSP60-induced expression of
COX-2. The c-Jun-NH2-terminal kinase (JNK), p44/42
mitogen-activated protein (MAP) kinase [extracellular signal-regulated
kinase 1/2 (ERK1/2)], and p38 MAP kinase were rapidly activated
by HSP60 in the macrophages. PD-98059, an inhibitor of
phosphorylation of ERK1/2, caused a marked inhibition of
HSP60-induced COX-2 and NOS-2 expression. Unexpectedly,
SB-203580, a p38 kinase antagonist, was found to block HSP60-induced
expression of COX-2, but not NOS-2. These data indicate that both
ERK1/2 kinase and p38 kinase play a role in regulating HSP60-induced
expression of COX-2.
nitric oxide; inflammation; cytokines; monocytes/macrophages
This article has been cited by other articles:
![]() |
J. M. Kuldo, J. Westra, S. A. Asgeirsdottir, R. J. Kok, K. Oosterhuis, M. G. Rots, J. P. Schouten, P. C. Limburg, and G. Molema Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1229 - C1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eligini, S. Stella Barbieri, V. Cavalca, M. Camera, M. Brambilla, M. De Franceschi, E. Tremoli, and S. Colli Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-{alpha} and phorbol ester in human endothelial cells Cardiovasc Res, February 15, 2005; 65(3): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jarrar, G. Y. Song, J. F. Kuebler, L. W. Rue, K. I. Bland, and I. H. Chaudry The Effect of Inhibition of a Major Cell Signaling Pathway Following Trauma Hemorrhage on Hepatic Injury and Interleukin 6 Levels Arch Surg, August 1, 2004; 139(8): 896 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bea, E. Blessing, B. J Bennett, C. C. Kuo, L. A. Campbell, J. Kreuzer, and M. E Rosenfeld Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis Cardiovasc Res, October 15, 2003; 60(1): 198 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, W. Tian, C. Tai, and D. M. Cohen Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR Am J Physiol Renal Physiol, August 1, 2003; 285(2): F281 - F288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |